Xeris Biopharma Holdings (XERS) Cash from Financing Activities (2020 - 2026)
Xeris Biopharma Holdings (XERS) reported Cash from Financing Activities of $1.94 million for Q2 2026, up 106.3% from $942,000 a year earlier.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Xeris Biopharma Holdings' Cash from Financing Activities came in at $6.69 million; for FY2025, it was $11.39 million, down 68.5% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of -38.2% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $36.17 million in FY2024, -$1.61 million in FY2023, $127.47 million in FY2022 (+367.8%) and $27.25 million in FY2021 (-78.4%).
- Five-year quarterly Cash from Financing Activities spans a low of -$8.84 million in Q1 2026 and a high of $78.19 million in Q1 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$8.84 million (Q1 2026), -$266,000 (Q4 2025) and $13.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Xeris Biopharma Holdings | 1.61 Bn | 1.17 Bn | 79.59 Mn | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | -8.84 Mn |
| Dec 31, 2025 | -266,000.00 |
| Sep 30, 2025 | 13.85 Mn |
| Jun 30, 2025 | 942,000.00 |
| Mar 31, 2025 | -3.14 Mn |
| Dec 31, 2024 | 398,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | 659,000.00 |
| Mar 31, 2024 | 35.19 Mn |
| Dec 31, 2023 | -1.23 Mn |
| Sep 30, 2023 | -72,000.00 |
| Jun 30, 2023 | 556,000.00 |
| Mar 31, 2023 | -863,000.00 |
| Dec 31, 2022 | 49.16 Mn |
| Sep 30, 2022 | -187,000.00 |
| Jun 30, 2022 | 310,000.00 |
| Mar 31, 2022 | 78.19 Mn |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 1,000.00 |
API Access
Xeris Biopharma Holdings Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();